Janina Schemme

Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support

N. Gebauer, D. Rades, H. Lehnert, 2016, Leukemia & lymphoma.

Favorable prognostic impact of RAS mutation status in multiple myeloma treated with high-dose melphalan and autologous stem cell support in the era of novel agents: a single center perspective

N. Gebauer, D. Rades, H. Lehnert, 2016, Leukemia & lymphoma.

The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.

Mithat Gönen, Tatiana Nikolskaya, Yuri Nikolsky, 2011, The Journal of clinical investigation.

Oncogenic mutations and chromosomal aberrations in primary extranodal diffuse large B-cell lymphomas of the thyroid--a study of 21 cases.

G. Brabant, N. Gebauer, A. Feller, 2015, The Journal of clinical endocrinology and metabolism.

Dysregulation of microRNAs in angioimmunoblastic T-cell lymphoma.

N. Gebauer, A. Feller, C. Thorns, 2015, Anticancer research.

Nodal marginal zone lymphoma: mutation status analyses of CD79A, CD79B, and MYD88 reveal no specific recurrent lesions

C. Thorns, H. Bernd, V. Bernard, 2017, Leukemia & lymphoma.

Hodgkin lymphoma as a novel presentation of familial DICER1 syndrome

A. Borkhardt, M. Kuhlen, H. Merz, 2016, European Journal of Pediatrics.

Oncogenic mutations and chromosomal aberrations in primary extranodal diffuse large B-cell lymphomas of the thyroid--a study of 21 cases.

G. Brabant, N. Gebauer, A. Feller, 2015, The Journal of clinical endocrinology and metabolism.

Favorable prognostic impact of RAS mutation status in multiple myeloma treated with high-dose melphalan and autologous stem cell support in the era of novel agents: a single center perspective

N. Gebauer, D. Rades, H. Lehnert, 2016, Leukemia & lymphoma.